Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Oruka Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-27 6:43 pm Purchase | 2025-02-10 | 13G | Oruka Therapeutics, Inc. ORKA | Venrock Healthcare Capital Partners III, L.P. | 4,148,428 11.100% | 606,487 (+17.12%) | Filing |
| 2024-11-14 5:49 pm Purchase | 2024-09-30 | 13G | Oruka Therapeutics, Inc. ORKA | Venrock Healthcare Capital Partners III, L.P. | 3,541,941 9.990% | 3,541,941 (New Position) | Filing |